vs
Side-by-side financial comparison of GRAIL, Inc. (GRAL) and INSEEGO CORP. (INSG). Click either name above to swap in a different company.
INSEEGO CORP. is the larger business by last-quarter revenue ($48.4M vs $43.6M, roughly 1.1× GRAIL, Inc.). INSEEGO CORP. runs the higher net margin — 1.0% vs -227.5%, a 228.5% gap on every dollar of revenue. On growth, GRAIL, Inc. posted the faster year-over-year revenue change (14.0% vs 0.6%). INSEEGO CORP. produced more free cash flow last quarter ($11.6M vs $-63.9M). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs 13.6%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.
GRAL vs INSG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.6M | $48.4M |
| Net Profit | $-99.2M | $469.0K |
| Gross Margin | — | 42.2% |
| Operating Margin | -285.4% | 2.7% |
| Net Margin | -227.5% | 1.0% |
| Revenue YoY | 14.0% | 0.6% |
| Net Profit YoY | -2.2% | 182.9% |
| EPS (diluted) | $-2.37 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.6M | $48.4M | ||
| Q3 25 | $36.2M | $45.9M | ||
| Q2 25 | $35.5M | $40.2M | ||
| Q1 25 | $31.8M | $31.7M | ||
| Q4 24 | $38.3M | $48.1M | ||
| Q3 24 | $28.7M | $54.0M | ||
| Q2 24 | $32.0M | $51.6M | ||
| Q1 24 | $26.7M | $37.5M |
| Q4 25 | $-99.2M | $469.0K | ||
| Q3 25 | $-89.0M | $1.4M | ||
| Q2 25 | $-114.0M | $507.0K | ||
| Q1 25 | $-106.2M | $-1.6M | ||
| Q4 24 | $-97.1M | $-566.0K | ||
| Q3 24 | $-125.7M | $9.0M | ||
| Q2 24 | $-1.6B | $624.0K | ||
| Q1 24 | $-218.9M | $-4.5M |
| Q4 25 | — | 42.2% | ||
| Q3 25 | — | 41.6% | ||
| Q2 25 | — | 41.1% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | — | 37.3% | ||
| Q3 24 | — | 34.8% | ||
| Q2 24 | — | 36.4% | ||
| Q1 24 | — | 35.3% |
| Q4 25 | -285.4% | 2.7% | ||
| Q3 25 | -346.2% | 4.7% | ||
| Q2 25 | -446.9% | 3.2% | ||
| Q1 25 | -482.5% | -1.3% | ||
| Q4 24 | -358.0% | 3.7% | ||
| Q3 24 | -640.5% | 1.9% | ||
| Q2 24 | -5133.8% | 3.6% | ||
| Q1 24 | -851.1% | -7.9% |
| Q4 25 | -227.5% | 1.0% | ||
| Q3 25 | -245.8% | 3.1% | ||
| Q2 25 | -320.7% | 1.3% | ||
| Q1 25 | -333.6% | -5.0% | ||
| Q4 24 | -253.8% | -1.2% | ||
| Q3 24 | -438.7% | 16.6% | ||
| Q2 24 | -4958.8% | 1.2% | ||
| Q1 24 | -819.3% | -11.9% |
| Q4 25 | $-2.37 | $-0.02 | ||
| Q3 25 | $-2.46 | $0.03 | ||
| Q2 25 | $-3.18 | $-0.03 | ||
| Q1 25 | $-3.10 | $-0.16 | ||
| Q4 24 | $-1.49 | $0.62 | ||
| Q3 24 | $-3.94 | $-0.06 | ||
| Q2 24 | $-51.06 | $-0.02 | ||
| Q1 24 | $-7.05 | $-0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $249.7M | $24.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.6B | $-4.0M |
| Total Assets | $2.9B | $93.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.7M | $24.9M | ||
| Q3 25 | $126.9M | $14.6M | ||
| Q2 25 | $127.4M | $13.2M | ||
| Q1 25 | $133.9M | $35.1M | ||
| Q4 24 | $214.2M | $39.6M | ||
| Q3 24 | $853.6M | $12.0M | ||
| Q2 24 | $958.8M | $49.0M | ||
| Q1 24 | $199.7M | $12.3M |
| Q4 25 | $2.6B | $-4.0M | ||
| Q3 25 | $2.2B | $-7.7M | ||
| Q2 25 | $2.3B | $-10.5M | ||
| Q1 25 | $2.4B | $-13.0M | ||
| Q4 24 | $2.5B | $-12.9M | ||
| Q3 24 | $2.6B | $-85.1M | ||
| Q2 24 | $2.7B | $-101.8M | ||
| Q1 24 | — | $-105.6M |
| Q4 25 | $2.9B | $93.8M | ||
| Q3 25 | $2.6B | $85.8M | ||
| Q2 25 | $2.7B | $83.1M | ||
| Q1 25 | $2.8B | $93.0M | ||
| Q4 24 | $3.0B | $100.0M | ||
| Q3 24 | $3.1B | $113.4M | ||
| Q2 24 | $3.3B | $149.6M | ||
| Q1 24 | — | $122.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.8M | $12.0M |
| Free Cash FlowOCF − Capex | $-63.9M | $11.6M |
| FCF MarginFCF / Revenue | -146.5% | 24.0% |
| Capex IntensityCapex / Revenue | 0.2% | 0.7% |
| Cash ConversionOCF / Net Profit | — | 25.50× |
| TTM Free Cash FlowTrailing 4 quarters | $-299.9M | $6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.8M | $12.0M | ||
| Q3 25 | $-63.2M | $3.2M | ||
| Q2 25 | $-77.0M | $-4.5M | ||
| Q1 25 | $-95.0M | $-3.5M | ||
| Q4 24 | — | $-14.2M | ||
| Q3 24 | $-104.6M | $14.8M | ||
| Q2 24 | $-171.8M | $27.6M | ||
| Q1 24 | $-207.3M | $5.2M |
| Q4 25 | $-63.9M | $11.6M | ||
| Q3 25 | $-63.6M | $3.1M | ||
| Q2 25 | $-77.3M | $-4.7M | ||
| Q1 25 | $-95.1M | $-3.5M | ||
| Q4 24 | — | $-14.3M | ||
| Q3 24 | $-105.6M | $14.8M | ||
| Q2 24 | $-173.2M | $27.6M | ||
| Q1 24 | $-209.8M | — |
| Q4 25 | -146.5% | 24.0% | ||
| Q3 25 | -175.8% | 6.7% | ||
| Q2 25 | -217.6% | -11.6% | ||
| Q1 25 | -298.6% | -11.0% | ||
| Q4 24 | — | -29.7% | ||
| Q3 24 | -368.4% | 27.4% | ||
| Q2 24 | -541.7% | 53.5% | ||
| Q1 24 | -785.3% | — |
| Q4 25 | 0.2% | 0.7% | ||
| Q3 25 | 1.1% | 0.2% | ||
| Q2 25 | 1.0% | 0.5% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 3.4% | 0.0% | ||
| Q2 24 | 4.3% | 0.0% | ||
| Q1 24 | 9.5% | 0.0% |
| Q4 25 | — | 25.50× | ||
| Q3 25 | — | 2.22× | ||
| Q2 25 | — | -8.81× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.65× | ||
| Q2 24 | — | 44.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
INSG
Segment breakdown not available.
